The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | The management of chlormethine gel-induced dermatitis
Marios Koumourtzis, MD, University of Athens Medical School, Andreas Syggros Hospital, Athens, Greece, outlines the management of chlormethine gel-induced dermatitis in patients with cutaneous T-cell lymphoma (CTCL). Dr Koumourtzis reports that patients should continue using chlormethine gel if they develop dermatitis, suggesting a reduction in the frequency of application. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
